- This topic has 5 replies, 4 voices, and was last updated 4 years ago by
Karina Dian Lestari.
-
AuthorPosts
-
-
2021-11-09 at 1:38 pm #32836
Arwin Jerome Manalo OndaParticipantDear all,
Kindly allow me to share my surveillance project on STIs. I selected this family of disease since their characteristics, progression, and effect on human lives warrant surveillance.
Let me know your comments or feedback on my project by replying to this thread.
Best,
Arwin
PS. In case you noticed that I was speaking fast (about to rap), I later realized during playback that I was speaking very slowly so I increased the playback speed. Haha sorry for this!
-
2021-11-13 at 12:27 pm #33026
Navin PrasaiParticipantThe presentation on Sexually transmitted Infection was clear and Objectives, Data Flow diagrams, Evaluation Indicators, and Legal Considerations were thoroughly explained. In the Stakeholders, from policymakers to General Public were included and the importance was highlighted which made the presentation more impressive.
-
2021-11-14 at 4:54 pm #33052
Arwin Jerome Manalo OndaParticipantThank you Navin for your kind feedback!
-
-
2021-11-13 at 5:23 pm #33029
SaranathKeymasterYes, you spoke very fast (just realized that you increase the playback speed). I like your slide presentation and of course their contents. I also like that you mentioned that the type of surveillance system might be changed depending on situations. Great work!
-
2021-11-14 at 4:56 pm #33053
Arwin Jerome Manalo OndaParticipantThank you Professor! As noted on the lecture materials, it may be inevitable for some diseases to adjust the type of surveillance system such that it will be more effective.
-
-
2021-11-14 at 8:47 pm #33060
Karina Dian LestariParticipantHi Arwin, thank you for sharing the project development. I realise you talk a little too fast, but in general, it is still a clear and great presentation!
Thank you for the insight to do the adaptive types of surveillance. Since the situation of the disease of changing and our knowledge of the diseases is also evolving, the surveillance system needs to be adapted and be able to capture the changes.
I agree with your emphasis on protecting the patient’s data in the data flow diagram. The patients’ data privacy must be protected and the variables that we are collecting are only the ones that are relevant for our analysis.
-
-
AuthorPosts
You must be logged in to reply to this topic. Login here
